Gilde Healthcare Establishes 6.57% Stake in SpyGlass Pharma Post-IPO
SGP is trading near its 52-week low of $24.71 (14% above the low).
Summary
Gilde Healthcare Holding B.V. and its affiliates reported a 6.57% beneficial ownership in SpyGlass Pharma, Inc. following the company's initial public offering, including a $5 million purchase in the offering.
Key Events · Ownership and Investor Activity · SGP
-
Establishes Significant Stake
Gilde Healthcare Holding B.V. and its affiliates reported beneficial ownership of 2,187,513 shares, representing 6.57% of SpyGlass Pharma's common stock.
-
IPO-Related Investment
The stake includes the conversion of Series D preferred stock and an additional $5 million purchase of common stock at $16.00 per share during the company's initial public offering on February 9, 2026.
-
Board Representation
Geoff Pardo, a partner at Gilde Healthcare, serves on the board of directors, indicating active involvement and oversight.
Analysis · SGP · Industrial Applications And Services
This Schedule 13D filing indicates that Gilde Healthcare, a venture capital firm, has established a significant 6.57% beneficial ownership in SpyGlass Pharma, Inc. following its recent initial public offering. The firm converted its Series D preferred stock into common shares and made an additional $5 million purchase of common stock in the IPO at $16.00 per share. This substantial stake, coupled with a partner serving on the board, signals strong institutional confidence in the company's prospects, especially as the stock trades near its 52-week high. This filing aligns with a cluster of other significant insider purchases reported this week, reinforcing positive sentiment around the company's market debut.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.5% of the 1055 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SGP was trading at $28.22 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $940.2M. The 52-week trading range was $24.71 to $29.47. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.